This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. Check our privacy policy here
News and Events
SunRock Biopharma and Escugen Forge Alliance to Develop First-in-Class CCR9-Targeted ADC
SunRock Biopharma and Escugen Forge Alliance to Develop First-in-Class CCR9-Targeted ADC Santiago de Compostela, Spain, and Shanghai, China . June 16,…
SunRock is pleased to share a new publication in Molecular Oncology highlighting the potential of SRB2 in pancreatic ductal adenocarcinoma
SRB2 is a humanized monoclonal #antibody developed by SunRock Biopharma, S.L targeting #CCR9. 🎯 This study demonstrates the efficacy of SRB2…
La compostelana SunRock y el Instituto de Oncología del Vall d’Hebron reciben 1,8 millones de euros de la Agencia Estatal de Investigación para el desarrollo de nuevos anticuerpos en el tratamiento del cáncer de ovario
El consorcio integrado por SunRock Biopharma, con sede en el Biopolo Sionlla, y por VHIO lidera el proyecto OVERCAD,…
Events
SunRock Biopharma, S.L will be attending the BIOInternational 2025 in Boston from 16-19 June
We are a biotech company with a pipeline of therapeutic antibodies for the treatment of cancer and immune-mediated inflammatory diseases, including…
SunRock Biopharma, S.L will be attending the BIOEquity 2025 in Bruges from 12-14 May
We are a biotech company with a pipeline of therapeutic antibodies for the treatment of cancer and immune-mediated inflammatory diseases, including…
SunRock Biopharma, S.L will be attending the BIOEurope Spring 2025 in Milan from 17-19 March
We are a biotech company with a pipeline of therapeutic antibodies for the treatment of cancer and immune-mediated inflammatory diseases, including…
SunRock Biopharma will be attending the 20th Congress of ECCO European Crohn’ and Colitis Organisation in Berlin from 19-22 February
We are a hashtag#biotech company with a pipeline of therapeutic hashtag#antibodies for the treatment of hashtag#inflammatory hashtag#bowel hashtag#disease. Are you attending…
Projects
